Prognostic factors for response and overall survival in 282 patients with higher-risk myelodysplastic syndromes treated with azacitidine - Raphaël Itzykson; Sylvain Thépot; Bruno Quesnel; François Dreyfus; Odile Beyne‐Rauzy; Pascal Turlure; Norbert Vey; Christian Récher; Caroline Dartigeas; Laurence Legros; Jacques Delaunay; Célia Salanoubat; et al. (2010)